PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Existing medicines show promise for treating stomach and bowel cancer

2014-02-04
(Press-News.org) Contact information: Vanessa Solomon
solomon@wehi.edu.au
61-393-452-971
Walter and Eliza Hall Institute

Rachel Steinhardt
rsteinhardt@licr.org
212-450-1582
Ludwig Institute for Cancer Research
Existing medicines show promise for treating stomach and bowel cancer

Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.

The finding, in preclinical models, that medicines called 'JAK inhibitors' reduce the growth of inflammation-associated stomach and bowel cancer provides the first evidence supporting their use in treating these cancers.

JAK inhibitors are currently used to treat the cancer-like condition myelofibrosis, and are being investigated in clinical trials for the treatment of conditions including leukaemia, lymphoma, lupus and rheumatoid arthritis.

Dr Emma Stuart, Dr Tracy Putoczki and Associate Professor Matthias Ernst from the Walter and Eliza Hall Institute made the discovery with colleagues while at the Melbourne-Parkville Branch of the Ludwig Institute for Cancer Research. Associate Professor Ernst is also currently a Ludwig Member. Their findings have been published in the journal Molecular Cancer Therapeutics.

Stuart said the discovery stemmed from the research team's long interest in the links between inflammation and cancers of the digestive tract. "Recently we have begun to unravel the complex signaling that occurs in inflamed tissues, such as when a person has a stomach ulcer or suffers from inflammatory bowel disease, and how this drives cancer development," she said.

"By understanding the molecules that are involved in promoting the survival and growth of cancer cells, we have been able to identify which of these molecules can be targeted with potential anti-cancer treatments. In this case, we determined that proteins called JAKs are involved in cancer formation in the stomach and bowel. It was exciting to discover that when JAKs were blocked with existing medications (JAK inhibitors), bowel and stomach cancer growth in experimental models was slowed, and many of the cancer cells were killed," Stuart said.

Ernst said the findings were significant as JAK inhibitors were already available and had shown success in clinical trials, particularly for treating cancer-like blood conditions.

"Our team's research has uncovered several proteins that could be valuable targets in treating cancers of the digestive tract," he said. "The reason this discovery is particularly exciting is clinical trials have already shown that JAK proteins can be safely and successfully inhibited in patients. We hope this will expedite bringing our research to possible clinical trials that may improve the outlook for people with stomach and bowel cancer," Ernst said.



INFORMATION:



The research was supported by the Australian National Health and Medical Research Council, the Ludwig Institute for Cancer Research and the Victorian Government.



ELSE PRESS RELEASES FROM THIS DATE:

Tricks of the trade: Study suggests how freelancers can land more jobs

2014-02-04
UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS – According to Elance.com, the online workplace lists more than three million registered freelancers ...

Stopping liver failure from painkiller overdose

2014-02-04
University of Adelaide researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller paracetamol (also known as acetaminophen). Published ...

A healthy balance

2014-02-04
STAT1 (signal transducer and activator of transcription 1) is a member of a family of transcription factors, cellular proteins that control whether and when ...

Happy people, safer sex

2014-02-04
Having a good week? It may lead to healthier choices. If you are a man with HIV, you may be more likely ...

When it comes to memory, quality matters more than quantity

2014-02-04
The capacity of our working memory is better explained by the quality of memories we can store than by their number, a team of psychology researchers has concluded. Their analysis, which appears in the latest ...

Despite burden, Sjögren's syndrome may not impede function

2014-02-04
BOSTON (February 4, 2014) —People living with Sjögren's syndrome, ...

Speech disrupts facial attention in 6-month-olds who later develop autism

2014-02-04
Philadelphia, PA, February 4, 2014 – From birth, infants naturally show a preference for human contact and interaction, including faces and voices. These ...

Patterns of particles generated by surface charges

2014-02-04
This news release is available ...

Horse gaits controlled by genetic mutation spread by humans, new study reveals

2014-02-04
From the Faroe Pony to the Spanish Mustang, fewer animals have played such a central role in human history as the horse. New research in Animal Genetics reveals that a horse's gait, an attribute ...

Economic crisis has made Europeans and Americans less likely to visit the doctor

2014-02-04
The global economic crisis has wrought havoc to economies on both sides of the Atlantic, but new research in Social Science Quarterly suggests it has also made both North Americans and Europeans ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] Existing medicines show promise for treating stomach and bowel cancer